Tag Archives: Kathleen Mudie

Systematic review of the epidemiological burden of ME/CFS across Europe: current evidence & EUROMENE research recommendations for epidemiology

Systematic review of the epidemiological burden of ME/CFS across Europe: current evidence and EUROMENE research recommendations for epidemiology, by Fernando Estévez-López, Kathleen Mudie, Xia Wang-Steverding, Inger Johanne Bakken, Andrejs Ivanovs, Jesús Castro-Marrero, Luis Nacul, Jose Alegre, Paweł Zalewski, Joanna Słomko, … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Evidence of clinical pathology abnormalities in people with ME/CFS…

Evidence of clinical pathology abnormalities in people with Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) from an analytic cross-sectional study, by Luis Nacul, Barbara de Barros, Caroline C Kingdon, Jacqueline M Cliff, Taane G Clark, Kathleen Mudie, Hazel M Dockrell, Eliana … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Evidence of clinical pathology abnormalities in people with ME/CFS…

The UK ME/CFS Biobank

The UK ME/CFS Biobank: A disease-specific biobank for advancing clinical research into myalgic encephalomyelitis/ chronic fatigue syndrome, by Eliana M. Lacerda, Kathleen Mudie, Caroline C. Kingdon, Jack D. Butterworth, Shennae O’Boyle, Luis Nacul in Frontiers in Neurology, 14 Nov 2018 [preprint Abstract: Myalgic encephalomyelitis/chronic … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on The UK ME/CFS Biobank

Hand grip strength as a clinical biomarker for ME/CFS & disease severity

Hand grip strength as a clinical biomarker for ME/CFS and disease severity, by Luis C Nacul, Kathleen Mudie, Caroline Kingdon, Taane G Clark, Eliana M Lacerda in Frontiers in Neurology, 5 Nov 2018 [Preprint] Research abstract: Background: The diagnosis of myalgic encephalomyelitis (ME/CFS) … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Hand grip strength as a clinical biomarker for ME/CFS & disease severity